Bitget Powers India Blockchain Tour in Hyderabad, Ahmedabad and Mumbai NEW DELHI, June 25, 2025 (GLOBE NEWSWIRE) — Bitget, the leading cryptocurrency exchange and Web3 company, has joined the 2025 edition of the India Blockchain Tour (IBT) as the exclusive “Powered by” partner for the Hyderabad, Ahmedabad, and Mumbai chapters.
Bitget Shines at Perú Blockchain Conference 2025 LIMA, Peru, June 25, 2025 (GLOBE NEWSWIRE) — Bitget, the leading cryptocurrency exchange, and Web3 company has concluded a successful showing at the Perú Blockchain Conference 2025 as a Silver Sponsor, reinforcing its commitment to advancing crypto education and adoption across Latin America.
Bitget Heads to Milan as Sponsor at ETHMilan 2025 VICTORIA, Seychelles, June 25, 2025 (GLOBE NEWSWIRE) — Bitget, the leading cryptocurrency exchange and Web3 company, proudly joins ETHMilan 2025 as the official Viscoti Sponsor, aligned with its expansion strategy in Europe and beyond. Held on June 24 at the iconic
Sharda: The Director General of Special Communications Organization has inaugurated the latest Freelancing Hub in Sharda, Neelum Valley. A large number of youth, teachers, dignitaries, and locals attended the inauguration ceremony.
According to Radi…
Abu Dhabi: Pakistan and the United Arab Emirates have signed Memorandums of Understanding and a Protocol to further deepen bilateral ties in fields such as investment, digital economy, and artificial intelligence. These agreements were finalized durin…
Karachi: International Day of the Seafarer is being observed today, focusing on the theme of creating a harassment-free environment aboard ships around the world.
According to Radio Pakistan, this year’s campaign, titled ‘My Harassment-Free Ship’, a…
Islamabad: Minister for Interior Mohsin Naqvi has underscored the necessity of implementing foolproof security measures during Muharram-ul-Haraam to counteract the nefarious intentions of anti-state elements.
According to Radio Pakistan, the ministe…
Collaboration enables testing of nitrosamine impurities, allowing sponsors to demonstrate acceptable use of rifampin in drug-drug interaction studies DURHAM, N.C., June 24, 2025 (GLOBE NEWSWIRE) — Fortrea (Nasdaq: FTRE) (the “Company”), a leading global contract research organization (CRO), today announced a strategic collaboration with Emery Pharma, a leading analytical and